These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10626918)

  • 1. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis.
    Davis JM; Janicak PG; Hogan DM
    Acta Psychiatr Scand; 1999 Dec; 100(6):406-17. PubMed ID: 10626918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder.
    Mitchell PB
    Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S99-107. PubMed ID: 10622184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine.
    Yerevanian BI; Koek RJ; Mintz J
    J Affect Disord; 2007 Nov; 103(1-3):5-11. PubMed ID: 17628692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate for acute mood episodes in bipolar disorder.
    Macritchie K; Geddes JR; Scott J; Haslam D; de Lima M; Goodwin G
    Cochrane Database Syst Rev; 2003; (1):CD004052. PubMed ID: 12535506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium carbonate: maintenance studies and consequences of withdrawal.
    Dunner DL
    J Clin Psychiatry; 1998; 59 Suppl 6():48-55; discussion 56. PubMed ID: 9674937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse.
    Bowden CL
    Curr Psychiatry Rep; 2000 Dec; 2(6):490-4. PubMed ID: 11123000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
    Roick C; Ahrens B; Becker T
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):283-5. PubMed ID: 10529071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):277-81. PubMed ID: 10529070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; 2001(2):CD003013. PubMed ID: 11406061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of mood stabilizer on the circadian system: possible implication for abnormalities in mood disorders].
    Ikeda M
    Nihon Yakurigaku Zasshi; 2007 Dec; 130(6):469-76. PubMed ID: 18079597
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
    Smith LA; Cornelius V; Warnock A; Bell A; Young AH
    Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.